Skip to main content
David Garfield, MD, Oncology, Centennial, CO

DavidHGarfieldMD

Oncology Centennial, CO

Breast Cancer, Thoracic Cancer

Associate Professor of Medicine at the U. of Colorado Comprehensive Cancer Center,

Dr. Garfield is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Garfield's full profile

Already have an account?

Summary

  • Dr. David Garfield is a retired medical oncologist now living in the Denver and Scottsdale areas. He received his medical degree from University of Illinois College of Medicine and was in practice almost 50 years. He specialized in breast cancer and thoracic cancer. He practiced medical oncology in Shanghai from 2010 to 2013 and still consults there.

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Hematology and Medical Oncology, 1969 - 1971
  • University of Minnesota
    University of MinnesotaResidency, Internal Medicine, 1967 - 1969
  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1964 - 1965
  • University of Cincinnati Medical Center Inc.
    University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1963 - 1964
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1963
  • Northwestern University
    Northwestern UniversityAccelerated Pre-Med Program, 1956 - 1959

Certifications & Licensure

  • CO State Medical License
    CO State Medical License Active through 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Top 75 (5%) Reviewers for Chest 2009
  • Service Award U.S. Oncology, 2001
  • Service Award American Cancer Society, Denver Unit, 2000
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer  
    Li B, Ren S, Li X, Wang Y, Garfield D, et al, Lung Cancer, 11/13/2013
  • Prevalence of lymph node metastases in superficial esophageal squamous cell carcinoma  
    Li B, Chen H, Xiang J, Zhang Y, Kong Y, Garfield DH, et al, J Thorac Cardiovasc Surg, 8/26/2013
  • Practicing Western Oncology in Shanghai, China: One Group's Experience  
    Garfield DH, Brenner HJ, Lu L, J Oncol Pract, 7/1/2013
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Effects of gefitinib (G) on bone metastases (BMs) in non-small cell lung cancer (NSCLC) patients (pts).
    Garfield DH, Zampa G, Cadranel J, et al, American Society of Clinical Oncology, 1/1/2006
  • "Phase 2 Trial of Single-Agent, Weekly Docetaxel as Second-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer."
    Canfield V, Garfield D, et al, American Society of Clinical Oncology, 1/1/2002
  • "Phase 2 Study of Sequential Chemotherapy Followed by Oral Maintenance Therapy with Orzel (UFT + Leukovorum) in Patients with Stage 3B and 4 Non-Small Cell Lung Cancer."
    Marsland, T, Garfield, D, et al, American Society of Clinical Oncology, 1/1/2002
  • Join now to see all

Lectures

  • "Phase II comparative study of two dose schedules of gemcitabine (Gem) as second-line therapy in patients with advanced non-small cell lung cancer (ANSCLC)." 
    Paris, France - 2/3/1998

Other

  • Monograph: "Molecular targeted therapy in oncology for the 21st century: bench to bedside." 
    Iwata KK, Haley JD, Garfield DH
    1/1/2006
  • Bronchioloalveolar Carcinoma (BAC): New insights in epidemiology, pathology, and novel strategies. 
    West H(J), Garfield D, Lung Cancer, Principles and Practice, publisher: Lippincott Williams @ Wilkins, vol. 3
    1/1/2004

Authored Content

  • Distribution and Clinical Utility of the 21-Gene Recurrence Score in Pure Mucinous Breast Cancer Patients: A Case-Control StudyAugust 2018